BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17294421)

  • 1. Endothelial cell KIT expression in human tumours.
    Sihto H; Tynninen O; Bützow R; Saarialho-Kere U; Joensuu H
    J Pathol; 2007 Mar; 211(4):481-8. PubMed ID: 17294421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
    J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour microvessel endothelial cell KIT and stem cell factor expression in human solid tumours.
    Sihto H; Tynninen O; Halonen M; Puputti M; Karjalainen-Lindsberg ML; Kukko H; Joensuu H
    Histopathology; 2009 Nov; 55(5):544-53. PubMed ID: 19912360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
    Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
    Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.
    Morrison RS; Yamaguchi F; Bruner JM; Tang M; McKeehan W; Berger MS
    Cancer Res; 1994 May; 54(10):2794-9. PubMed ID: 8168112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
    Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
    Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors.
    Verheul HM; Salumbides B; Van Erp K; Hammers H; Qian DZ; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2008 Jun; 14(11):3589-97. PubMed ID: 18519793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
    Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
    Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
    Zhu DM; Li DC; Zhang ZX; Zhang XY
    Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma.
    Furuya M; Nishiyama M; Kimura S; Suyama T; Naya Y; Ito H; Nikaido T; Ishikura H
    J Pathol; 2004 May; 203(1):551-8. PubMed ID: 15095478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
    Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions.
    Haller F; Löbke C; Ruschhaupt M; Schulten HJ; Schwager S; Gunawan B; Armbrust T; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Oct; 216(2):225-35. PubMed ID: 18729075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-kit proto-oncogene product in breast tissue.
    Yared MA; Middleton LP; Meric F; Cristofanilli M; Sahin AA
    Breast J; 2004; 10(4):323-7. PubMed ID: 15239791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the c-kit mRNA in human aortic endothelial cells.
    Miyamoto T; Sasaguri Y; Sugama K; Azakami S; Morimatsu M
    Biochem Mol Biol Int; 1994 Oct; 34(3):513-20. PubMed ID: 7530545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of stem cell factor and c-kit receptor in human asthmatic airways.
    Al-Muhsen SZ; Shablovsky G; Olivenstein R; Mazer B; Hamid Q
    Clin Exp Allergy; 2004 Jun; 34(6):911-6. PubMed ID: 15196279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
    Yu ZT; Zhao HF; Shang XB
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
    Sawyer EJ; Poulsom R; Hunt FT; Jeffery R; Elia G; Ellis IO; Ellis P; Tomlinson IP; Hanby AM
    J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF).
    Han ZB; Ren H; Zhao H; Chi Y; Chen K; Zhou B; Liu YJ; Zhang L; Xu B; Liu B; Yang R; Han ZC
    Carcinogenesis; 2008 Oct; 29(10):1853-61. PubMed ID: 18339685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
    Ngan BY; Forte V; Campisi P
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.